Avoid common mistakes on your manuscript.
Dear Editor,
Coronavirus SARS-CoV-2 has infected over 110 million people and the COVID-19 pandemic claimed more than 2.4 million lives worldwide as of February 17th, 2021. SARS-CoV-2 causes substantial pulmonary disease including pneumonia and acute respiratory distress syndrome (ARDS), especially in individuals at old age with multiple comorbidities and immunocompromisation [1]. The pathological features of COVID-19 lungs greatly resemble those seen in severe acute respiratory syndrome (SARS) and Middle Eastern respiratory syndrome (MERS) coronavirus infection. However, the pathogenesis of the disease is largely unclear.
Pathological findings showed the typical features of diffuse alveolar damage (DAD) in SARS-CoV-2 caused ARDS [2]. Lung biopsy of a COVID-19 patient showed bilateral DAD with desquamation of pneumocytes, hyaline membrane formation, and alveolar edema [2]. SARS-CoV-2 infected ciliated cells in the airway and type 2 pneumocytes (AT2) in alveolar regions [3]. Viral particles can be detected in AT2 cells and KRT5+ airway cells [4]. Notably, a significant depletion of AT1 and increased proliferation of AT2 cells were observed, suggesting that AT2 cells are mobilized to regenerate the damaged alveoli in COVID-19 lungs [4]. In the trachea and large airways, KRT5+ cells proliferated extensively, while in smaller airways predominant proliferating cells were lineage undetermined [4]. Interstitial mononuclear inflammatory infiltrates, dominated by lymphocytes, were seen in biopsied lungs [2]. Recently, an array of extrapulmonary manifestations have been reported in many organs and tissues [5]. Recent reviews also suggest viral sepsis in COVID-19 patients, as well as endothelial dysfunction and thrombotic microangiopathy [1]. We think that these extrapulmonary manifestations can be explained by the failure of the respiratory epithelial cells and their basement membrane. In this letter, by immunofluorescence co-staining, we examined the integrity of the respiratory epithelium, endothelium and the respiratory epithelial basement membrane, and discovered the loss of respiratory epithelial integrity and the epithelial basement membrane in COVID-19 patients.
The alveolar basement membrane is a critical component of blood–air barrier (BAB, or alveolar–capillary barrier) which prevents the formation of air bubbles in the blood, and from blood entering the alveoli. The alveolar basement membrane acts as scaffolds guiding morphogenesis, tissue repair, micromolecular permeability regulation, and cell movement. To demonstrate the structures and functions of the basement membranes in COVID-19 patients, we first examined COVID-19 lung sections from autopsies of three patients and three healthy donors (patient information was detailed in our previous study [4] and in supplemental materials). Immunoactivity of SARS-CoV-2 viral capsid spike (S) protein can be seen in the COVID-19 lung sections (Fig. 1a). Immunostaining for Laminin, the major component of basement membrane, on healthy lung sections gave clear and smooth basement membrane bands surrounding both alveoli and blood vessels (Fig. 1a, #1 and 2 areas). In COVID-19 lung sections, the alveolar and vascular structures were severely damaged, and the lumens were filled with nucleated and non-nucleated cells (Fig. 1a). Although positive Laminin staining could be detected in lung interstitial tissues, the bands were interrupted, and scattered Laminin protein was found in interstitial tissues. Moreover, fibrous Laminin was lining the alveolar-like structures in COVID-19 lung sections (Fig. 1a, area #3). Condensed cell areas were also identified (#4 area), suggesting fibrosis foci in COVID-19 lungs. Vascular-like round structures were found in these condensed cell areas (#3 and 4 areas) (Fig. 1a), suggesting vasculogenesis in those areas. These pathological changes can be found in all three cases of COVID-19 lungs (Supplementary Fig. 1).
To further confirm epithelial basement membrane defects, we used another antibody to detect Laminin γ3 and observed similar staining structures in healthy lungs (Fig. 1b). In tile scanning COVID-19 sections, severely damaged lung structures and disrupted basement membrane bands were apparent. At higher magnifications, we found abnormal basement membrane structures in both severely damaged lung areas (#5 area) and less damaged areas (#6 area) (Fig. 1b). These observations were also confirmed in the other two COVOD-19 lungs.
To better locate the basement membrane, we co-stained the endothelial cell marker, CD31, with Laminin. In healthy lung sections, the endothelium was either well lined in blood vessels (arrowhead) or was evenly distributed in the alveolar walls (boxed area) and was surrounded by Laminin+ basement membrane (Fig. 1c, arrows). In COVID-19 lung sections, CD31 showed much less immunostaining signal in alveolar areas, and vascular endothelium was also disrupted (arrowheads). More importantly, the basement membrane was severely damaged (Fig. 1c, arrows).
We next examined AT2 cells and found dispersed HTII-280+ AT2 in healthy lung sections and smooth Laminin+ basement membrane right underneath AT2 cells (Fig. 1d, arrows). However, in COVID-19 sections, HTII-280+ cells were present in multiple cell clusters. Most AT2 cells were desquamated from the alveolar walls and were larger and more flattened compared to healthy AT2 cells (Fig. 1d, asterisks and arrows). The expression levels of laminin were lower in the alveolar walls and were barely detected in AT2 regions, suggesting damaged AT2 cell basement membrane (Fig. 1d). These pathological changes could be found in all three cases of COVID-19 lungs.
Taken together, we demonstrate that SARS-CoV-2 caused severe damage to the human lung. Cell-filled alveoli and condensed fibrosis-like cell regions are identified in COVID-19 lungs. The alveolar endothelium is severely damaged and the epithelial cell boundaries (BABs) are broken, leading to the inflow of cells and viral particles from the lung alveoli into blood. AT2 cells accumulate to form colonies and most cells are desquamated from the alveoli-like structures and exhibit altered cell morphologies. Most interestingly, the alveolar basement membranes, including epithelial and vascular basement membranes, are severely disrupted. Scattered and disconnected basement membrane components were identified in COVID-19 lungs. All these damages resembled the changes in alveolar and microvascular endothelial structure ARDS. We speculate that when the dams (the respiratory epithelial cells and their basement membrane) are breached, the flood (viral particles) can reach other organs, tissues, and cells which usually would not see the virus. Because of the heterogeneous nature of the “flood”, a wide array of extrapulmonary manifestations then present. These findings provide pathological insights in understanding the mechanisms of alveolar damage and alveolar repair. Further investigations into the underlying mechanisms of alveolar regeneration and basement membrane repair should help in developing strategies for combating lung damage as well as extrapulmonary injuries in COVID-19 patients. Also, in coordinate with the systemic inflammatory response induced “cytokine storm” and thromboembolism in COVID-19 patients, severity of basement membrane damage is likely to be a possible factor to clinical severity and mortality.
Availability of data and materials
All data and material relevant to this publication is available upon reasonable request.
Abbreviations
- ARDS:
-
Acute respiratory distress syndrome
- SARS:
-
Severe acute respiratory syndrome
- MERS:
-
Middle Eastern respiratory syndrome
- DAD:
-
Diffuse alveolar damage
- AT2:
-
Type 2 pneumocytes
- AT1:
-
Type 1 pneumocytes
- BAB:
-
Blood–air barrier
References
Li H, Liu L, Zhang D, Xu J, Dai H, Tang N, et al. SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet. 2020;395(10235):1517–20. https://doi.org/10.1016/S0140-6736(20)30920-X.
Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–2. https://doi.org/10.1016/S2213-2600(20)30076-X.
Hou YJ, Okuda K, Edwards CE, Martinez DR, Asakura T, Dinnon KH 3rd, et al. SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract. Cell. 2020. https://doi.org/10.1016/j.cell.2020.05.042.
Fang Y, Liu H, Huang H, Li H, Saqi A, Qiang L, et al. Distinct stem/progenitor cells proliferate to regenerate the trachea, intrapulmonary airways and alveoli in COVID-19 patients. Cell Res. 2020;30(8):705–7. https://doi.org/10.1038/s41422-020-0367-9.
Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017–32. https://doi.org/10.1038/s41591-020-0968-3.
Acknowledgements
The authors thank the members of our laboratories for helpful discussion and critical reading of the manuscript. We thank Dr. L. Dobbs of UCSF providing antibodies for the study.
Consent to participate
All patients provided informed consent.
Funding
This work was supported by National Institutes of Health grants P01- HL108793 (PWN and DJ) and HL132996 and HL152293 (J.Q).
Author information
Authors and Affiliations
Contributions
D.J, J. Q, and P.W.N: study conceivation. D. J, J.Q, and X. L experiments design, data analysis and manuscript writing. X.L: immunohistological staining and pathological analysis. Y.F: paraffin and frozen sections preparation. The author(s) read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
All experiments were performed were approved by the Institutional Review Board at Cedars-Sinai Medical Center and Columbia University Irving Medical Center and were in accordance with the guidelines outlined by the Institutional Review Board.
Consent for publication
Yes.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Additional file 1.
Supplementary Information for Materials and Methods. Supplementary Fig.1. Laminin staining on three COVID-19 patients and one normal lung sections.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Liu, X., Fang, Y., Noble, P.W. et al. Disruption of respiratory epithelial basement membrane in COVID-19 patients. Mol Biomed 2, 8 (2021). https://doi.org/10.1186/s43556-021-00031-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s43556-021-00031-6